Navigation Links
Attacks in Biological Technology

ViroPharma Receives Complete Response Letter for Cinryze(TM) Supplemental Biologics License Application for Acute Treatment of Hereditary Angioedema

... inhibitor [human]) as a treatment for acute attacks of hereditary angioedema (HAE). The FDA has ... Cinryze is already successfully preventing attacks of HAE in many patients, there remains an unmet ... by FDA for routine prophylaxis against angioedema attacks in adolescent and adult patients with HAE. C1 ...

Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial

... (p=0.0013). The risk of procedure-related heart attacks was 4.9 percent in patients who took prasugrel ... (p=0.0002). Non-procedure-related heart attacks included spontaneous heart attacks, which could be differentiated from procedure-related heart attacks that were associated with the artery-opening ...

ViroPharma Incorporated Honored by the National Organization for Rare Disorders

... debilitating, and potentially life threatening attacks of swelling affecting the larynx, abdomen, face, ... October 2008 for routine prophylaxis against HAE attacks in adults and adolescents. In February 2009, ... for Cinryze for the treatment of acute attacks of HAE. If approved, Cinryze may be the first C1 ...

New Discoveries on a Fingertip Test for Screening Silent Heart Disease Promising Results of Recent Clinical Studies to be Presented during the 2009 American College of Cardiology Conference, March 29th - April 1st in Orlando

... Every year, over 1.4 million heart attacks occur in the United States and many more worldwide. About half of these heart attacks happen in healthy-looking individuals who had no ... status quo (Problem 1). The other half of heart attacks happens in patients with known heart disease, who ...

ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results

... (sBLA) for Cinryze for treatment of acute attacks of HAE; Granted priority review by the ... for Cinryze sBLA for treatment of acute attacks of HAE, with a Prescription Drug User Fee Act ... for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary ...

European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI

... since more than 700,000 people die from heart attacks in the European Union each year," said Takashi ... an important medical need. Survivors of heart attacks have a substantial risk of suffering from one or ... drome Acute coronary syndrome includes heart attacks and unstable angina (chest pain). Coronary heart ...

Risky Business: New Survey Suggests Many Americans Live Dangerously, Even When They Say They Aren't 'Risk Takers'

... to lower it can decrease the number of heart attacks and strokes suffered in this country every year," ... and smoking cessation would reduce heart attacks by 36 percent over the next three decades(ii). A ... aspirin counseling for the prevention of heart attacks and recurrent stroke. Encouraging physicians ...

RAND study finds increase in piracy and terrorism at sea

... to combat lower consequence (but more probable) attacks that could strike cruise ships or passenger ... the period saw only a modest spike in terrorist attacks and plots at sea, including the 2004 bombing of ... as researchers suspect nearly half of all piracy attacks are not reported, usually because of fears about ...

RAND study finds increase in piracy and terrorism at sea

... to combat lower consequence (but more probable) attacks that could strike cruise ships or passenger ... the period saw only a modest spike in terrorist attacks and plots at sea, including the 2004 bombing of ... as researchers suspect nearly half of all piracy attacks are not reported, usually because of fears about ...

C1-Esterase Inhibitor Concentrate Rapidly Relieves Abdominal and Facial Attacks in Patients with Hereditary Angioedema, According to Pivotal Study

... that C1-INH is effective treatment for HAE attacks across all body sites PHILADELPHIA, March 18 ... relieves acute abdominal and facial swelling attacks in patients with hereditary angioedema (HAE), a ... therapy's effectiveness in rapidly relieving HAE attacks in peripheral body locations, such as the hands ...

Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration

... were 22 fewer patients with heart attacks and five more non-CABG-related TIMI major ... Daiichi Sankyo Company, Limited. Acute heart attacks and unstable angina, called acute ... people continue to experience recurrent heart attacks and 450,000 people die from ...

ViroPharma Incorporated Reports First Quarter 2009 Financial Results

... (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also ... studies including the pivotal Phase 3 study of Cinryze in acute HAE attacks and the ongoing open-label study of Cinryze for acute treatment of HAE, ...

PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel

... need for advanced medical countermeasures to combat the risk of terrorist attacks with biological or chemical weapons is a significant global concern," ... novel products which are intended to save lives and deter terrorist attacks against our citizens. We are very proud to support these initiatives and ...

ViroPharma To Acquire Lev Pharmaceuticals

... recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. While there is no approved therapy for acute HAE attacks in the U.S., a commercially available C1 inhibitor has been used in Europe ...

Boys in the Hood

... tools that are convenient, stealthy, and swift. Chemical and biological attacks can be accidental, but if a particular protectee, is in a particular ... has indeed included weapons of mass destruction witness the anthrax attacks in 2001, notes Jalal Mapar, S&Ts Program Manager for the EH-15 program. ...

Alexza Reports 2008 First Quarter Financial Results and Updates Development of Product Candidates

... Alexza is developing AZ-002 for the acute treatment of panic attacks associated with panic disorder. The Company completed enrollment of ... and AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder are in Phase 2 testing. Product candidates ...

Boys in the Hood

... tools that are convenient, stealthy, and swift. Chemical and biological attacks can be accidental, but if a particular protectee, is in a particular ... has indeed included weapons of mass destruction witness the anthrax attacks in 2001, notes Jalal Mapar, S&Ts Program Manager for the EH-15 program. ...

Shire plc: Core Portfolio of Products Delivers 20% Sales Growth

... colitis; launches will continue in certain EU and RoW countries in 2009 and 2010; - FIRAZYR for the symptomatic treatment of acute attacks of HAE; launches will continue in certain European and Latin American countries during 2009 and 2010; - INTUNIV for the treatment of ...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

... Percocet(R) and Percodan(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; OPANA(R) ...

Human Genome Sciences Announces New Order for Raxibacumab (ABthrax(TM)) from U.S. Government

... said H. Thomas Watkins, President and Chief Executive Officer, HGS. "We all hope never to see a large-scale version of the inhalation anthrax attacks that took place in 2001, but HGS is proud to play a role in making sure that we are prepared as a nation to limit the human cost of such an attack ...

Evidence for a New Genetic Link to Therapeutic Efficacy for Alzheimer's Disease

... which there is no cure. In the United States, 5.2 million people are living with AD, and it has become the sixth leading cause of death. The disease attacks the brain's cells, resulting in loss of memory, executive function and language skills. AD significantly impacts millions of family members ...

Novel drug discovery tool could identify promising new therapies for Parkinson's disease

... of Environmental Health Sciences, and from the Michael J. Fox Foundation and the American Parkinson's Disease Association. Parkinson's disease attacks cells in a part of the brain responsible for motor control and coordination. As those neurons degenerate, the disease leads to progressive ...

Monitoring water through a snake's eyes

... Once in use, the sensor system would be one of the first real-time water monitors in the United States to provide protection from chemoterrorism attacks ― a threat to which U.S. water supplies are particularly susceptible. "It's unlikely that someone will poison the water supply in Afghanistan," ...

Syngenta and Evogene to Collaborate on Soybean Nematode Resistance

... will receive exclusive licensing rights to candidate genes discovered by Evogene for use in soybean. Soybean nematode is a soil parasite which attacks the roots of developing plants, and is one of the most devastating and yield limiting pests of soybean. Soybean growers may lose more than 20 percent ...

ViroPharma to Present at Two June Healthcare Conferences

... methicillin-resistant strains. ViroPharma commercializes Cinryze(TM) (C1 esterase inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's ...

PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer

... to extend the lives of people with advanced prostate cancer. Administered subcutaneously, it induces a specific, targeted immune response that attacks prostate cancer cells. Conventional chemotherapy currently used to treat prostate cancer has limited survival rates and is often associated with ...

Disabled and other vulnerable groups more susceptible to terrorism fears

... 2004 and January 2005. Respondents were asked the color of the country's alert level at that time, as well as how often they worried about terrorist attacks and how often they avoided activities because of those fears. Researchers found that the mentally ill, the disabled, African Americans, ...

Structure of enzyme against chemical warfare agents determined

... the squid Loligo vulgaris , is able to rapidly and efficiently detoxify chemical warfare agents such as Sarin, which was used in the Tokyo subway attacks in 1995. A detailed understanding of the mechanism by which enzymes catalyze chemical reactions is necessary for efforts aiming to improve their ...

Monitoring water through a snake's eyes

... Once in use, the sensor system would be one of the first real-time water monitors in the United States to provide protection from chemoterrorism attacks ― a threat to which U.S. water supplies are particularly susceptible. "It's unlikely that someone will poison the water supply in Afghanistan," ...

First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter

... NIRS is a novel technique recently cleared by the FDA for the identification of lipid core plaques, the structures suspected to cause most heart attacks and complicate stenting procedures. Prof. Serruys stated that, "The composition of atherosclerotic plaques is important in assessing the ...

The Concerned Shareholders of Biovail Say Biovail Has Misled Shareholders

... while considering the interests of its shareholders. xxxxxxxxx Biovail's continued irrational attacks on the Concerned Shareholders and the requisition should demonstrate that the current Board in unable to operate constructively and is unable to ...

ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009

... Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's ...

SiliconSky GPS Designs First AGPS-Enabled Asthma Inhaler for Landmark Research Program

... trends, including exact time and geographic location of uses. The result was a GPS-enabled standard asthma inhaler. Due to the nature of asthma attacks and inhaler use, the medical device needed to function inside buildings as well as outdoors. The unit had to be small enough to fit in the palm of a ...

Disabled and other vulnerable groups more susceptible to terrorism fears

... 2004 and January 2005. Respondents were asked the color of the country's alert level at that time, as well as how often they worried about terrorist attacks and how often they avoided activities because of those fears. Researchers found that the mentally ill, the disabled, African Americans, ...

Structure of enzyme against chemical warfare agents determined

... the squid Loligo vulgaris , is able to rapidly and efficiently detoxify chemical warfare agents such as Sarin, which was used in the Tokyo subway attacks in 1995. A detailed understanding of the mechanism by which enzymes catalyze chemical reactions is necessary for efforts aiming to improve their ...

New Weapon in BioDefense Research: NanoLogix Kit Speeds Rapid Diagnostics of Anthrax and Bubonic Plague

... can mean the difference between life and death, between a widespread public panic and a smooth containment strategy. In the event of future attacks such as occurred in 2001, the hope is that the BNP's(TM) ability to assist in determining the threat posed by biologic agents will contribute to a ...

Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors

... PERCOCET(R) and PERCODAN(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; OPANA(R) ...

Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session

... is such that there is no change to our standard treatment practices. We look forward to beginning a Phase II trial." Of the 1 million heart attacks in the U.S. each year, nearly 20% are severe enough to cause ventricular remodeling. Amorcyte's patented technologies and cGMP (current good ...

Batman Teams with Senator Katherine Laforge to Help Free America from OPEC

... in Texas and Louisiana. Bio diesel is an industry that is attacked by many adversaries that perceive it as a threat to their future profits. The attacks take on numerous forms. Misinformation is one commonly employed to destroy an industry. You will find falsities that creating biodiesel takes food ...

ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes

... Staphylococcus aureus , including methicillin-resistant strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's ...
Other Contents
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... their offering. One major trend ... multimodal biometric systems. Multimodal biometric systems utilize more ... and identification purposes. This helps to reduce the ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
(Date:12/24/2014)... Dr. Svetlana Gomer, MGS Tewksbury Dental, ... gathered with US Marines on November 14, 2014 for ... the Toys for Tots Literacy Program. This year’s ... books and audio books for the Toys for Tots ... Christmas. It represents another major strike in the battle ...
(Date:12/24/2014)... 2014 The report offers details on ... various market dynamics such as the key trends, the ... wait time for U.S. sports medicine, the impact of ... the challenges faced by the market. , Browse report ... The report also provides an overview of the global ...
(Date:12/24/2014)... Verde Pointe Dental Associates 2014 Ugly Holiday ... years homemade Christmas sweater lit up, but this years overall ... is Tandy Wilson for the second year in a row. ... Kimmerling DDS. "She took pictures of the entire staff and ... , "Every year I enjoy stopping by the dental ...
(Date:12/24/2014)... Dental implants benefit millions of individuals ... They offer the strongest and most secure hold for ... of tooth replacement. They will never slip out of ... for support, and they prevent the jaw from shrinking ... they are not suitable candidates for dental implants because ...
(Date:12/24/2014)... 24, 2014 Attorneys handling talcum powder ... update to their website, the Talcum Powder Ovarian ... talcum powder class action lawsuits and ovarian cancer claims. ... ovarian cancer updates at their website, which serves as ... ovarian cancer claims are not the same as class ...
Breaking Medicine News(10 mins):Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 3Health News:Sports Medicine Market Report 2014: Global Industry Analysis, Share, Size, Trends, Growth and Forecast report 2Health News:Verde Pointe Dental Associates Announces the 2014 Ugly Sweater Holiday Contest Winner 2Health News:Innovative Dental Implant Procedure to Gain Momentum in the New Year 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 2Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 3Health News:Talcum Powder Attorneys Explain Class Action Lawsuits 4
Other TagsOther Tags